Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases
about
Timing and extent of response in colorectal cancer: critical review of current data and implication for future trialsColorectal Liver Metastases: A Critical Review of State of the ArtRAS mutations predict radiologic and pathologic response in patients treated with chemotherapy before resection of colorectal liver metastases.Positive regulatory effects of perioperative probiotic treatment on postoperative liver complications after colorectal liver metastases surgery: a double-center and double-blind randomized clinical trial.Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG).Genetic variations in angiopoietin and pericyte pathways and clinical outcome in patients with resected colorectal liver metastases.Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases.A 5-year recurrence-free survivor with over ten colorectal liver metastases undergoing FOLFOX plus bevacizumab followed by two-stage hepatectomyVascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer.CT texture analysis in colorectal liver metastases: A better way than size and volume measurements to assess response to chemotherapy?Non-size-based response criteria to preoperative chemotherapy in patients with colorectal liver metastases: the morphologic response criteriaPredictors of Safety and Efficacy of 2-Stage Hepatectomy for Bilateral Colorectal Liver Metastases.Modified two-dimensional response as surrogate marker of overall survival in patients with metastatic colorectal cancer.RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases.Pre-hepatectomy carcinoembryonic antigen (CEA) levels among patients undergoing resection of colorectal liver metastases: do CEA levels still have prognostic implications?Computed tomograpy evaluation of morphological changes, clinical response and survival in colorectal cancer liver metastasis treated by regorafenib: A case report.Novel tyrosine kinase inhibitors for renal cell carcinoma.Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis.Advances in understanding of colorectal liver metastasis and implications for the clinic.Current opinion on optimal systemic treatment for metastatic colorectal cancer: outcome of the ACTG/AGITG expert meeting ECCO 2013.Diagnosis and Management of Hepatitis C Virus Infection.Hepatic Resection for Disappearing Liver Metastasis: a Cost-Utility Analysis.Positive Impact of Epidural Analgesia on Oncologic Outcomes in Patients Undergoing Resection of Colorectal Liver Metastases.Beyond Histologic Staging: Emerging Imaging Strategies in Colorectal Cancer with Special Focus on Magnetic Resonance Imaging.CEA change after neoadjuvant chemotherapy including bevacizumab and clinical outcome in patients undergoing liver resection for colorectal liver metastases.Efficacy and safety of aflibercept in metastatic colorectal cancer pretreated with bevacizumab: A report of five cases.Local tumour progression after percutaneous ablation of colorectal liver metastases according to RAS mutation status.Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations.Morphological response contributes to patient selection for rescue liver resection in chemotherapy patients with initially un-resectable colorectal liver metastasis.Nomogram including pretherapeutic parameters for prediction of survival after SIRT of hepatic metastases from colorectal cancer.Detection of Circulating Tumor Cells at Surgery and at Follow-Up Assessment to Predict Survival After Two-Stage Liver Resection of Colorectal Liver Metastases.Retrospective analysis of pathological response in colorectal cancer liver metastases following treatment with bevacizumab.SSAT State-of-the-Art Conference: New Frontiers in Liver Surgery.Response to preoperative chemotherapy predicts survival in patients undergoing hepatectomy for liver metastases from gastric and esophageal cancer.Long-term postoperative survival prediction in patients with colorectal liver metastasis.Fluorine-18-fluorodeoxyglucose positron emission tomography as an objective substitute for CT morphologic response criteria in patients undergoing chemotherapy for colorectal liver metastases.Pseudoprogression on bevacizumab treatment: tumor-dynamics in the modern era of systemic treatment for metastatic colorectal cancer.Changes in CT morphology can be an independent response marker for patients receiving regorafenib for colorectal liver metastases: retrospective pilot study.Individualized Treatment Sequencing Selection Contributes to Optimized Survival in Patients with Rectal Cancer and Synchronous Liver Metastases.
P2860
Q26797292-29BFB662-3484-46B6-8FDF-53F94F0DA49DQ28070400-B320252B-90D8-4824-9B19-80AFBBFE0249Q35054390-177C9257-0629-4483-A46D-E69E3673B029Q35218618-18C4A679-8795-4CFC-A6FD-EB44979362CBQ35622772-B889D8C7-AC7D-4F48-B5B5-8E18B6C05079Q35637857-6ED10FEA-776F-4D5E-A357-7B9E1C625DDEQ35709696-1DD290A3-B568-4402-A379-CBB993A1716DQ36226042-48A125EB-F54F-4A10-B1F9-409043C26B44Q36286704-7D8B733F-8C7F-43DE-85D3-994B91DD37BAQ36719842-9E137F50-643F-49E4-9A19-6F9C21CEAB74Q36860539-36F31F35-FE69-4CBE-8D0D-8BDE6E638BB3Q37047788-FEC486A9-9C9C-42E3-8E0B-2BE93E324670Q37375230-6AEAD519-15EE-4740-8859-36795B69B266Q37375848-8B64C806-F852-4878-A23B-1370F7EBF208Q37407384-67CEA296-1F04-43C2-8C66-7B182E3562D8Q37484579-3C99E06B-1A01-4CAD-B8A4-D6F611CF8DD0Q37582423-8EDCE563-2DF3-4BCC-ADA5-E0466A35052BQ38168944-758E88C9-E09F-472B-83B7-9CEA9273A574Q38199370-34D02083-5CBB-4947-9C4B-CD59C508CB0AQ38230654-E4BA7E18-74FC-4B56-8516-E9A40B617284Q38241395-4637A5E0-A4B8-4833-B3BD-9E2B146B2408Q38327430-09FACD1F-9681-4357-83EE-E2A207B74D8DQ38528603-E53CE8BB-835E-4BD0-BD4D-717100D95408Q38618728-8E90C8AF-33C2-4BB5-BDD9-54579E6F42A4Q38943223-0D73CAB2-1489-47A5-BFAF-2C14F8480484Q39111898-9CFF49D8-ED86-4191-A55E-91051F0F51E4Q39144205-56F9B8A2-FA5A-4B99-AA99-19C7B7A517DDQ40317208-C7D293E9-E1B2-47D6-B1D1-4431DEFAC8B3Q40674654-D02309E3-A9FF-4389-8B73-E92B626DBB85Q41142528-5945DF0A-DF5A-48C6-8478-3DFA320A2B4CQ41344992-BEC2C6FD-075B-4960-B257-AB12331C691CQ43424195-0EEAAA25-492C-4519-9357-9B27FD4289A6Q44895824-F95663F5-EF65-4261-A3ED-1B82E34B9EBFQ45296595-6E93B5FB-68AD-4252-9EBB-B45073E4F253Q46972090-761495D3-4557-4702-8806-FEDFBA0ECD40Q47129929-4DE824EA-B05B-4E16-98AB-AD9F86A94200Q48227698-122E76A0-530F-4DC5-ABF0-82DD7DCFCA1FQ48300792-7D302F77-419C-4559-80EA-94864B0AB549Q49603085-BCB2A9B1-2AF9-4AA1-BA98-4E32E6DB3573Q50001196-3B6D93C7-B5AF-497F-842D-81C26D761E37
P2860
Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Optimal morphologic response t ...... hepatic colorectal metastases
@ast
Optimal morphologic response t ...... hepatic colorectal metastases
@en
type
label
Optimal morphologic response t ...... hepatic colorectal metastases
@ast
Optimal morphologic response t ...... hepatic colorectal metastases
@en
prefLabel
Optimal morphologic response t ...... hepatic colorectal metastases
@ast
Optimal morphologic response t ...... hepatic colorectal metastases
@en
P2093
P2860
P356
P1476
Optimal morphologic response t ...... hepatic colorectal metastases
@en
P2093
Chusilp Charnsangavej
Dipen M Maru
Evelyne M Loyer
Jean-Nicolas Vauthey
Junichi Shindoh
Piyaporn Boonsirikamchai
Steven A Curley
Thomas A Aloia
Yun Shin Chun
P2860
P304
P356
10.1200/JCO.2012.45.2854
P407
P577
2012-11-13T00:00:00Z